Influence of particle size on regional lung deposition--what evidence is there?
暂无分享,去创建一个
[1] E. Daviskas,et al. Deposition of aqueous aerosol of technetium-99m diethylene triamine penta-acetic acid generated and delivered by a novel system (AERx) in healthy subjects , 1999, European Journal of Nuclear Medicine.
[2] R. Malcolmson,et al. Dry powder formulations for pulmonary delivery , 1998 .
[3] E. Daviskas,et al. Lung deposition of mannitol powder aerosol in healthy subjects. , 2006, Journal of aerosol medicine : the official journal of the International Society for Aerosols in Medicine.
[4] P. Jaques,et al. Total Lung Deposition of Ultrafine Particles in Elderly Subjects During Controlled Breathing , 2005, Inhalation toxicology.
[5] D. Tashkin,et al. Evaluation of efficacy and safety of flunisolide hydrofluoroalkane for the treatment of asthma. , 2003, Clinical therapeutics.
[6] N. Kenya. Montreal Protocol Parties: Adjustments and Amendments to the Montreal Protocol on Substances that Deplete the Ozone Layer , 1991, International Legal Materials.
[7] G. P. Martin,et al. Particulate Interactions in Dry Powder Formulations for Inhalation , 2000 .
[8] C. Leach,et al. Influence of particle size and patient dosing technique on lung deposition of HFA-beclomethasone from a metered dose inhaler. , 2005, Journal of aerosol medicine : the official journal of the International Society for Aerosols in Medicine.
[9] E. Daviskas,et al. SPECT Imaging for Radioaerosol Deposition and Clearance Studies. , 2006, Journal of aerosol medicine : the official journal of the International Society for Aerosols in Medicine.
[10] Pieter Zanen,et al. The optimal particle size for parasympathicolytic aerosols in mild asthmatics , 1995 .
[11] Gerhard Scheuch,et al. Left-to-right asymmetry of aerosol deposition after shallow bolus inhalation depends on lung ventilation. , 2009, Journal of aerosol medicine and pulmonary drug delivery.
[12] S. Newman,et al. Scintigraphic assessment of therapeutic aerosols. , 1993, Critical reviews in therapeutic drug carrier systems.
[13] Warren H. Finlay,et al. Particle deposition in the respiratory tract , 2019, The Mechanics of Inhaled Pharmaceutical Aerosols.
[14] B. Hammer,et al. Magnetic Deposition of Aerosols Composed of Aggregated Superparamagnetic Nanoparticles , 2010, Pharmaceutical Research.
[15] S. Newman,et al. Lung deposition of salbutamol in healthy human subjects from the MAGhaler dry powder inhaler. , 2002, Respiratory medicine.
[16] Jeffry D. Schroeter,et al. Fundamental Effects of Particle Morphology on Lung Delivery: Predictions of Stokes' Law and the Particular Relevance to Dry Powder Inhaler Formulation and Development , 2002, Pharmaceutical Research.
[17] M. Dolovich,et al. Labiris NR, Dolovich MB. Pulmonary drug delivery: part II. the role of inhalant delivery devices and drug formulations in therapeutic effectiveness of aerosolized medications , 2004 .
[18] V. Sollich,et al. Lung deposition in cystic fibrosis patients using an ultrasonic or a jet nebulizer. , 2003, Journal of aerosol medicine : the official journal of the International Society for Aerosols in Medicine.
[19] E. Daviskas,et al. Effect of particle size of dry powder mannitol on the lung deposition in healthy volunteers. , 2008, International journal of pharmaceutics.
[20] H. Frijlink,et al. Positron Emission Tomography Studies of Human Airways Using an Inhaled β-Adrenoceptor Antagonist, S-11 C-CGP 12388 , 2005 .
[21] E. Daviskas,et al. Changes in lung deposition of aerosols due to hygroscopic growth: a fast SPECT study. , 2002, Journal of aerosol medicine : the official journal of the International Society for Aerosols in Medicine.
[22] A. Coates,et al. Rapid pulmonary delivery of inhaled tobramycin for Pseudomonas infection in cystic fibrosis: A pilot project , 2008, Pediatric pulmonology.
[24] M. Newhouse,et al. Factors that affect the efficacy of inhaled corticosteroids for infants and young children. , 2010, The Journal of allergy and clinical immunology.
[25] Y. Cheng,et al. Lung Deposition of Droplet Aerosols in Monkeys , 2008 .
[26] J. Lammers,et al. The efficacy of a low-dose, monodisperse parasympathicolytic aerosol compared with a standard aerosol from a metered-dose inhaler , 1998, European Journal of Clinical Pharmacology.
[27] Dongming Hwang,et al. Three-dimensional simulations of airways within human lungs , 2007, Cell Biochemistry and Biophysics.
[28] L. Borgström,et al. Lung deposition of budesonide in asthmatics: a comparison of different formulations , 1998 .
[29] G. Scheuch,et al. Deposition of Foradil P in human lungs: comparison of in vitro and in vivo data. , 2004, Journal of aerosol medicine : the official journal of the International Society for Aerosols in Medicine.
[30] J. Lammers,et al. Optimal particle size for beta 2 agonist and anticholinergic aerosols in patients with severe airflow obstruction. , 1996, Thorax.
[31] N Lotan,et al. Large porous particles for pulmonary drug delivery. , 1997, Science.
[32] O. Usmani,et al. Regional Lung Deposition and Bronchodilator Response as a Function of β2-Agonist Particle Size , 2005 .
[33] M. Dolovich,et al. 18F-fluorodeoxyglucose positron emission tomographic imaging of pulmonary functions, pathology, and drug delivery. , 2009, Proceedings of the American Thoracic Society.
[34] Richard J Martin. Therapeutic significance of distal airway inflammation in asthma. , 2002, The Journal of allergy and clinical immunology.
[35] D. J. Alexander,et al. Human safety and pharmacokinetics of the CFC alternative propellants HFC 134a (1,1,1,2-tetrafluoroethane) and HFC 227 (1,1,1,2,3,3, 3-heptafluoropropane) following whole-body exposure. , 2000, Regulatory toxicology and pharmacology : RTP.
[36] S. Newman,et al. Radionuclide imaging technologies and their use in evaluating asthma drug deposition in the lungs. , 2003, Advanced drug delivery reviews.
[37] Bhavna,et al. Nano-salbutamol dry powder inhalation: a new approach for treating broncho-constrictive conditions. , 2009, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[38] C. Leach,et al. Improved airway targeting with the CFC-free HFA-beclomethasone metered-dose inhaler compared with CFC-beclomethasone. , 1998, The European respiratory journal.
[39] A. James,et al. The structure of large and small airways in nonfatal and fatal asthma. , 1993, The American review of respiratory disease.
[40] A. Elaissari,et al. Assessment methods of inhaled aerosols: technical aspects and applications , 2009, Expert opinion on drug delivery.
[41] Dolovich Ma. Influence of inspiratory flow rate, particle size, and airway caliber on aerosolized drug delivery to the lung. , 2000 .
[42] A Birchall,et al. In vivo measurement of unattached radon progeny deposited in the human respiratory tract. , 2001, Radiation protection dosimetry.
[43] C Kleinstreuer,et al. Targeted drug-aerosol delivery in the human respiratory system. , 2008, Annual review of biomedical engineering.
[44] M. Affrime,et al. Regional lung deposition of a technetium 99m-labeled formulation of mometasone furoate administered by hydrofluoroalkane 227 metered-dose inhaler. , 2000, Clinical therapeutics.
[45] M. Dolovich,et al. Imaging drug delivery and drug responses in the lung. , 2004, Proceedings of the American Thoracic Society.
[46] S. Farr. The physico-chemical basis of radiolabelling metered dose inhalers with 99mTc. , 1996, Journal of aerosol medicine : the official journal of the International Society for Aerosols in Medicine.
[47] K. Ensing,et al. Characterisation of β2-adrenoceptors, using the agonist []formoterol and positron emission tomography , 1998 .
[48] Newman,et al. Imaging techniques for assessing drug delivery in man. , 1999, Pharmaceutical science & technology today.
[49] M. R. Bailey,et al. EFFECT OF PARTICLE SIZE ON SLOW PARTICLE CLEARANCE FROM THE BRONCHIAL TREE , 2008, Experimental lung research.
[50] H. Chrystyn. Methods to identify drug deposition in the lungs following inhalation. , 2001, British journal of clinical pharmacology.
[51] K. Amighi,et al. Formulation strategy and use of excipients in pulmonary drug delivery. , 2010, International journal of pharmaceutics.
[52] W. Hofmann,et al. Aerosol Drug Delivery Optimization by Computational Methods for the Characterization of Total and Regional Deposition of Therapeutic Aerosols in the Respiratory System , 2007 .
[53] Z. Lee,et al. Regional distribution and kinetics of inhaled pharmaceuticals. , 2000, Current pharmaceutical design.
[54] G. Scheuch,et al. PULMONARY DEPOSITION OF MONODISPERSE AEROSOLS IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE , 2003, Experimental lung research.
[55] K. Amighi,et al. Correlations between cascade impactor analysis and laser diffraction techniques for the determination of the particle size of aerosolised powder formulations. , 2008, International journal of pharmaceutics.
[56] J. Fleming,et al. A Technique for Simulating Radionuclide Images from the Aerosol Deposition Pattern in the Airway Tree , 1997 .
[57] C. Robertson,et al. Aerosol deposition in infants with cystic fibrosis , 1996, Pediatric pulmonology.
[58] Richard B Thompson,et al. MRI measurement of regional lung deposition in mice exposed nose-only to nebulized superparamagnetic iron oxide nanoparticles. , 2008, Journal of aerosol medicine and pulmonary drug delivery.
[59] Hak-Kim Chan,et al. In vitro/in vivo comparisons in pulmonary drug delivery. , 2008, Journal of aerosol medicine and pulmonary drug delivery.
[60] M. Dolovich,et al. Synthesis and in vitro evaluation of 18F- and 19F-labeled insulin: a new radiotracer for PET-based molecular imaging studies. , 2006, Journal of medicinal chemistry.
[61] J. Fleming,et al. 3D in silico modeling of the human respiratory system for inhaled drug delivery and imaging analysis. , 2007, Journal of pharmaceutical sciences.
[62] J. Wildhaber,et al. A complementary combination of delivery device and drug formulation for inhalation therapy in preschool children. , 2004, Swiss medical weekly.
[63] G. Rudolf,et al. Intercomparison of Experimental Regional Aerosol Deposition Data , 1989 .
[64] G. Hedenstierna,et al. Deposition of Terbutaline in the Large or Small Airways: A Single-Center Pilot Study of Ventilation-Perfusion Distributions and Airway Tone , 2002 .
[65] Z. Lee,et al. Imaging studies of biodistribution and kinetics in drug development , 2003 .
[66] A. Clark,et al. A Comparison of the Pulmonary Bioavailability of Powder and Liquid Aerosol Formulations of Salmon Calcitonin , 2008, Pharmaceutical Research.
[67] M. Apte,et al. Unattached radon progeny as an experimental tool for dosimetry of nanoaerosols: Proposed method and research strategy , 2010, Inhalation toxicology.
[68] David Price,et al. Choosing inhaler devices for people with asthma: current knowledge and outstanding research needs. , 2010, Respiratory medicine.
[69] Dongming Hwang,et al. In silico modeling of asthma. , 2003, Advanced drug delivery reviews.
[70] B. Shekunov,et al. Particle Size Analysis in Pharmaceutics: Principles, Methods and Applications , 2007, Pharmaceutical Research.
[71] Albert H. L. Chow,et al. Particle Engineering for Pulmonary Drug Delivery , 2007, Pharmaceutical Research.
[72] I. Gonda,et al. Targeting by deposition , 1992 .
[73] G. Kim Prisk,et al. Deposition of inhaled particles in the human lung is more peripheral in lunar than in normal gravity , 2008, European Journal of Applied Physiology.
[74] W. Kreyling,et al. Corrections in dose assessment of 99mTc radiolabeled aerosol particles targeted to central human airways using planar gamma camera imaging. , 2009, Journal of aerosol medicine and pulmonary drug delivery.
[75] P Hagedoorn,et al. Characterization of inhalation aerosols: a critical evaluation of cascade impactor analysis and laser diffraction technique. , 2002, International journal of pharmaceutics.
[76] Ali A. Rostami,et al. Computational Modeling of Aerosol Deposition in Respiratory Tract: A Review , 2009, Inhalation toxicology.
[77] W. Koch,et al. Particle deposition in the lung of the Göttingen minipig , 2010, Inhalation toxicology.
[78] S. Cryan,et al. In vivo animal models for drug delivery across the lung mucosal barrier. , 2007, Advanced drug delivery reviews.
[79] Jolyon P Mitchell,et al. Cascade impactors for the size characterization of aerosols from medical inhalers: their uses and limitations. , 2003, Journal of aerosol medicine : the official journal of the International Society for Aerosols in Medicine.
[80] W. Busse,et al. Efficacy and safety overview of a new inhaled corticosteroid, QVAR (hydrofluoroalkane-beclomethasone extrafine inhalation aerosol), in asthma. , 2000, The Journal of allergy and clinical immunology.
[81] J. Wildhaber,et al. Deposition of aerosols in infants and children. , 2004, Journal of aerosol medicine : the official journal of the International Society for Aerosols in Medicine.
[82] P. Iozzo,et al. In vivo imaging of insulin receptors by PET: preclinical evaluation of iodine-125 and iodine-124 labelled human insulin. , 2002, Nuclear medicine and biology.
[83] J. Heyder,et al. Intrapulmonary distribution of deposited particles. , 1999, Journal of aerosol medicine : the official journal of the International Society for Aerosols in Medicine.
[84] I. Wilding,et al. Gamma scintigraphy in the evaluation of pharmaceutical dosage forms , 2004, European Journal of Nuclear Medicine.
[85] R. Schlesinger,et al. Comparative deposition of inhaled aerosols in experimental animals and humans: a review. , 1985, Journal of toxicology and environmental health.
[86] Simon Cawthorne,et al. Particle engineering techniques for inhaled biopharmaceuticals. , 2006, Advanced drug delivery reviews.
[87] G. Smaldone,et al. Effect of tubing deposition, breathing pattern, and temperature on aerosol mass distribution measured by cascade impactor. , 2003, Journal of aerosol medicine : the official journal of the International Society for Aerosols in Medicine.
[88] James D. Crapo,et al. Lower Respiratory Tract Structure of Laboratory Animals and Humans: Dosimetry Implications , 1993 .
[89] Z. Lee,et al. Pulmonary distribution and kinetics of inhaled [11C]triamcinolone acetonide. , 2000, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[90] Stefan Eberl,et al. Aerosol deposition and clearance measurement: a novel technique using dynamic SPET , 2001, European Journal of Nuclear Medicine.
[91] R. Condos,et al. Lung deposition and respirable mass during wet nebulization. , 2003, Journal of aerosol medicine : the official journal of the International Society for Aerosols in Medicine.
[92] M. L. Laucks,et al. Aerosol Technology Properties, Behavior, and Measurement of Airborne Particles , 2000 .